Coffee Break & Poster Viewing Session
Updates in the Management of Breast Cancer (EBC, LABC, MBC)
-Systemic therapy ( Chemotherapy, Endocrine therapy & Emerging therapies)
-Radiation Therapy
Introduction to Haematological Malignancies
Paeds I: Wilms Tumour
& Neuroblastoma
Approach to Anaemia
Cancer Biology I
CVL Insertion & Care
Station 1: Percutaneous
Station 2: PICC
Paeds II: Medulloblastoma & Ependymoma
Iron Defficiency Anaemia
Cancer Biology I
Paeds III: Ewing Sarcoma & Rhabdomyosarcoma
Advancing Clinical Trials in Africa I
Infusion Pumps
Station 1: Infusaid & Infuse-A-Port
Station 2: Chemotherapy Infusion Pumps
Paeds IV:
Osteosarcoma, Retinoblastoma, Brainstem Glioma
Leukopaenia & Leukocytosis: General Approach
Advancing Clinical Trials in Africa II
Plenary Session 2
8.00 – 9.00 AM
VENUE: RUPA HALL
Paeds V:
Germ Cell Tumours
Normal Coagulation & Coagulation Factor Defficiency
Cancer Genetics I
Breast & Cervical Ca Screening
Station 1: Breast Ca Screening
Station 2: Cervical Ca screeinig
Plasma Cell Dyscrasias
Haemophillia & other rare bleeding disorders
Cancer Genetics II
Coffee Break & Poster Viewing Session (10.30 AM – 11.00 AM)
Industry Sponsored Satellite Session
11. 00 AM – 12. 30 PM
Updates in the Management of Prostate Cancer (EBC, LABC, MBC)
-Surgery
-Systemic therapy ( Chemotherapy, Endocrine Therapy & Emerging Therapies)
-Radiation Therapy
LUNCH & POSTER VIEWING SESSION
12.30 PM – 1.30 PM
Multiple Myeloma I
Disorders of Platelet Function
Pharmacology I: Basics of Cancer Chemotherapy & Immunotherapy
LEEP & Colposcopy
Station 1: LEEP
Station 2: Colposcopy
Multiple Myeloma II
Thrombocytopaenia: General Approach
Pharmacology I: Basics of Cancer Chemotherapy & Immunotherapy
Expert Led Panel Discussion
2.30 – 3.30 PM
VENUE: RUPA HALL
Tea Break & Poster Session
4.30 – 5.30 PM EAT
Hypercoagulable states
Global Oncology
as a Discipline
Breast Mammography
Soft Tissue Sarcomas
Antithtrombotic therapy & Antiplatelet therapy
Global Oncology
as a Discipline II
Plenary Session 3
8.00 – 9.00 AM
VENUE: RUPA HALL
Hodgkin Lymphoma
(Classical)
Hepatocellular Ca
Pharmacology II: Targetted therapy A
(EGFR,VEGFR,HER2,PARP,MTor, ALK, HH..)
Breast Ultrasonography
Hodgkin Lymphoma
(NLPHL)
Biliary Tract Ca (Cholangiocarcinoma & Gall Bladder Ca)
Pharmacology II: Targetted therapy A
(EGFR,VEGFR,HER2,PARP,MTor, ALK, HH..)
Coffee Break & Poster Viewing Session (10.30 AM – 11.00 AM)
Industry Sponsored Satellite Session
11. 00 AM – 12. 30 PM
Updates in the Management of Lung Cancer (SCLC,NSCLC)
-Surgery
-Systemic therapy ( Chemotherapy & Emerging targetted therapies)
-Radiation Therapy
LUNCH & POSTER VIEWING SESSION
12.30 PM – 1.30 PM
Indolent NHL
HIV – Related Malignancies
Haematopoetic Growth Factors
Pharmacology III: Targetted Therapy B
(CD20, CD30,CD33,BCR-ABL/KIT,FLT3)
Pharmacology III: Targetted Therapy B
(CD20, CD30,CD33,BCR-ABL/KIT,FLT3)
Breast Ultrasound Guided Core Biopsy
Aggressive NHL
Carcinoma of Unknown Primary
Bone Marrow Failure
Pharmacology III: Targetted Therapy B
(CD20, CD30,CD33,BCR-ABL/KIT,FLT3)
Expert Led Panel Discussion
2.30 – 3.30 PM
VENUE: RUPA HALL
CNS Malignancies I (Gliomas & Meningioma)
Transfusion Medicine I
Pharmacology IV:
Targetted Therapy C
(CDK4/6, PI3K,IDH1/2)
Bone Marrow Aspiration & Biopsy
CNS Malignancies II (Pituitary Adenoma & Craniopharyngioma)
Transfusion Medicine II
Pharmacology IV:
Targetted Therapy C
(CDK4/6, PI3K,IDH1/2) II
Tea Break & Poster Session
4.30 – 5.30 PM EAT
Plenary Session 4
8.00 – 9.00 AM EAT
VENUE: RUPA HALL
Industry Sponsored Satellite Session
9. 30 AM – 10. 30 PM EAT
Updates in the Management of Endocrine & Neuroendocrine Tumours
Number of participants is limited!
Don't miss your seat. Join the discussion in AnCHOR now
Do not miss the speech
of our special guest
Prof. Dinesh PendharkarDay 3, 11:30, Room A
You don’t want to miss the plenary sessions at the conference or the breakout rooms with leading oncologists and hematologists from around the world. Grab your chance to listen to keynote speeches from world-renowned speakers like Prof. Dinesh Pendakar, leading partners, government representatives among others.